RGLS Stock | | | USD 1.64 0.07 4.46% |
Regulus Therapeutics financial indicator trend analysis is much more than just breaking down Regulus Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Regulus Therapeutics is a good investment. Please check the relationship between Regulus Therapeutics Cash Per Share and its Begin Period Cash Flow accounts. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our
How to Invest in Regulus Therapeutics guide.
Cash Per Share vs Begin Period Cash Flow
Cash Per Share vs Begin Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Regulus Therapeutics Cash Per Share account and
Begin Period Cash Flow. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Regulus Therapeutics' Cash Per Share and Begin Period Cash Flow is -0.21. Overlapping area represents the amount of variation of Cash Per Share that can explain the historical movement of Begin Period Cash Flow in the same time period over historical financial statements of Regulus Therapeutics, assuming nothing else is changed. The correlation between historical values of Regulus Therapeutics' Cash Per Share and Begin Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Cash Per Share of Regulus Therapeutics are associated (or correlated) with its Begin Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Begin Period Cash Flow has no effect on the direction of Cash Per Share i.e., Regulus Therapeutics' Cash Per Share and Begin Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.21 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Cash Per Share
Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.
Most indicators from Regulus Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Regulus Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regulus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in bureau of economic analysis.
For more information on how to buy Regulus Stock please use our
How to Invest in Regulus Therapeutics guide.At this time, Regulus Therapeutics'
Tax Provision is comparatively stable compared to the past year.
Issuance Of Capital Stock is likely to gain to about 18
M in 2024, whereas
Selling General Administrative is likely to drop slightly above 9.4
M in 2024.
Regulus Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Regulus Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Regulus Therapeutics fundamental ratios Accounts
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Additional Tools for Regulus Stock Analysis
When running Regulus Therapeutics' price analysis, check to
measure Regulus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regulus Therapeutics is operating at the current time. Most of Regulus Therapeutics' value examination focuses on studying past and present price action to
predict the probability of Regulus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regulus Therapeutics' price. Additionally, you may evaluate how the addition of Regulus Therapeutics to your portfolios can decrease your overall portfolio volatility.